Renexxion Ireland Ltd. Announces Issuance of Sixth New U.S. Patent Covering New Naronapride Trihydrate Formulation, Dosage Forms, and Treatment of GI Disorders

This pharmaceutical composition, dosage form, and treatment method patent is part of a comprehensive IP portfolio covering naronapride, Renexxion's lead compound and a potential best-in-class, orally ...

Oncolytics Biotech® Expands Its Gastrointestinal Tumor Scientific Advisory Board with the Addition of Dr. Eileen O’Reilly, Dr. Neil Segal, and Dr. Van Morris

Oncolytics Biotech® Inc. (Nasdaq: ONCY) ("Oncolytics" or the "Company"), a clinical-stage immunotherapy company developing pelareorep, today announced the expansion of its gastrointestinal ("GI") ...
Becker's ASC

10 major GI deals that defined 2025

From major acquisitions to AI-powered partnerships, here are 10 major GI deals to know from 2025: 1. In January, Optum subsidiary SCA Health, one of the largest ASC chains in the country, acquired ...
Healio

The Development of GI Psychology with Megan Riehl, PsyD

Please provide your email address to receive an email when new articles are posted on . In this podcast episode, Megan Riehl, PsyD, discusses symptoms and solutions in GI psychology, building ...
EurekAlert!

Low glycemic index rice seen as promising solution to mitigate Asia’s diabetes crisis

Los Baños, Philippines (17 December 2024) - A new paper recently published by scientists from the International Rice Research Institute (IRRI) and the Max Planck Institute is exploring the potential ...
Medscape

The Overlooked Link Between Vitamin D and GI Health

Vitamin D is a fat-soluble vitamin long associated with bone health, but emerging evidence is revealing that it has a broader role, particularly in gut health. Both animal and human studies have ...